Simmering nicely
The pre-close update demonstrates ongoing strong trading across the Group, with revenues ahead 50%...
Read moreAcquisitions underpin outlook in recovering markets
Strong FY21 results were in line with our most recently upgraded forecasts (May 2021) and reinforce...
Read moreUnbreakable quantum encryption: the ‘holy grail’
Arqit’s quantum encryption product aims to protect any form of device from hacking, with a fully...
Read more
Investing in Growth
While RUA Life Sciences’ FY 2021 results echoed some of the challenges from last year’s pandemic,...
Read moreAccelerated momentum
In its Trading Update for the six months ended 30 June 2021 Mpac reports that the upturn seen in H2...
Read moreCleared to launch BMK08 / Ectosan Vet in Norway
Norway’s Medicines Agency (NoMA) has approved Benchmark Holdings’ parasiticide BMK08 (imidacloprid)...
Read more
A glaring differential in validation
Recent transactions and the introduction of a new Act of the US Congress are further advancing the...
Read moreMinor bump in the road to 510k submission
RUA have released a precautionary announcement noting a minor delay to the 510k submission for its...
Read more- Prev
- 1 of 50 pages
- Next
Register to be first
Get research on the companies that interest you straight to your inbox
